Key Highlights
- NeuroFlow acquires Owl, enhancing behavioral health technology.
- Creates largest end-to-end behavioral health measurement solution.
- Extends capabilities across primary and specialty care settings.
- Over 400 behavioral health assessments and robust analytics.
- Supports payers and providers in all 50 states.
Source: Direct
Notable Quotes
- “Behavioral health conditions are present everywhere, not just in behavioral health clinics, and in many cases those conditions go unidentified or untreated, leading to higher costs and worse clinical outcomes.” — Chris Molaro, Chief Executive Officer at NeuroFlow
- “Owl is dedicated to improving clinical outcomes in partnership with behavioral health providers and demonstrating meaningful savings for the healthcare ecosystem.” — Eric Meier, Chief Executive Officer at Owl
- “We can’t simply add more providers to address this issue; we need effective solutions to identify behavioral health risk early and seamlessly connect individuals to the right care at the right time.” — Dr. Tom Hawes, Managing Director at Blue Venture Fund
SoHC's Take
NeuroFlow’s acquisition of Owl marks a significant advancement in the behavioral health technology landscape. By combining NeuroFlow’s AI-driven insights and Owl’s measurement-based care capabilities, the merger creates a comprehensive platform that addresses critical gaps in behavioral health care. This integration not only enhances the ability to monitor and manage patient outcomes but also scales solutions to meet the rising demand for mental health services across various healthcare settings. The strategic focus on data-driven approaches and collaboration with key stakeholders positions NeuroFlow as a transformative leader in delivering holistic and effective behavioral health care. This merger is poised to set new standards in the industry, driving better patient outcomes and more efficient care delivery.
